Inhibition of fibrinolysis by recombinant factor VIIA in plasma from patients with severe hemophilia A.
Lisman T, Mosnier LO, Lambert T, et al.
Blood 2002;99(1):175-179.
Review by
Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial.
An excellent study about the use of AT III in septic patients. Carefully conducted study: the description in the method section is outstanding. It is... Read More